European PACS and digital x-ray developer Ferrania Imaging Technologies is restructuring its European operations. Adrian Stevens will lead the European Life Imaging sales and marketing teams in Europe with direct responsibility for the European region,
European PACS and digital x-ray developer Ferrania Imaging Technologies is restructuring its European operations. Adrian Stevens will lead the European Life Imaging sales and marketing teams in Europe with direct responsibility for the European region, including Italy, Germany, U.K., Ireland, Scandinavia, Benelux, Switzerland, Austria, France, and Iberia. He will retain his responsibilities as managing director for Ferrania U.K. Ian Wilson will assume responsibility for the Life Imaging business, taking the position of business manager of the division for the U.K. and Nordic region.
ADT Partners, an international investment group, has agreed to acquire a significant stake in Ferrania. Permira Funds, formally called Schroder Ventures, will continue to hold a majority position.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Meta-Analysis Shows Merits of AI with CTA Detection of Coronary Artery Stenosis and Calcified Plaque
April 16th 2025Artificial intelligence demonstrated higher AUC, sensitivity, and specificity than radiologists for detecting coronary artery stenosis > 50 percent on computed tomography angiography (CTA), according to a new 17-study meta-analysis.
New bpMRI Study Suggests AI Offers Comparable Results to Radiologists for PCa Detection
April 15th 2025Demonstrating no significant difference with radiologist detection of clinically significant prostate cancer (csPCa), a biparametric MRI-based AI model provided an 88.4 percent sensitivity rate in a recent study.